Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (07 Apr 2026): | 820.54 |
| Day range: | 818.80 / 837.04 |
| Change abs./rel.: | -14.99 / -1.79% |
| Year range: | 544.13 / 883.94 |
| Name | Number of shares |
|---|---|
| IPSEN SA | 0.594982 |
| ASTRAZENECA PLC | 0.640621 |
| NOVARTIS AG | 0.328495 |
| MERCK KGAA | 0.164374 |
| GSK PLC | 2.139852 |
| GALDERMA GROUP AG | 0.118127 |
| SANOFI SA | 0.451737 |
| BAYER AG | 0.624132 |
| HALEON PLC | 4.208757 |
| UCB SA | 0.348672 |
| SANDOZ GROUP AG | 0.340632 |
| RECORDATI SPA | 0.663004 |
| ROCHE HOLDING AG | 0.371572 |
| GENMAB A/S | 0.457756 |
| NOVO NORDISK A/S | 0.757348 |